 | • レポートコード：MRCLP3DB2374 • 出版社/出版日：LP Information / 2023年12月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2-3営業日） • 産業分類：化学＆材料 |
| Single User | ￥549,000 (USD3,660) | ▷ お問い合わせ |
| Corporate User | ￥1,098,000 (USD7,320) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| LPインフォメーション社の最新調査レポート「医薬品用酢酸イカチバントの世界市場」は、過去の販売実績から2022年の世界の医薬品用酢酸イカチバントの総販売量を検討し、2023年から2029年の予測される医薬品用酢酸イカチバントの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の医薬品用酢酸イカチバントの市場規模を掲載し、XXX百万米ドル規模の世界の医薬品用酢酸イカチバント市場の詳細な分析を提供します。本インサイトレポートは、世界の医薬品用酢酸イカチバント業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。 また、本資料では、加速する世界の医薬品用酢酸イカチバント市場における各社の独自のポジションをより深く理解するために、医薬品用酢酸イカチバント製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。 世界の医薬品用酢酸イカチバント市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。医薬品用酢酸イカチバントの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。医薬品用酢酸イカチバントの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。医薬品用酢酸イカチバントの欧州市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。 医薬品用酢酸イカチバントの世界主要メーカーとしては、ALEMBIC PHARMACEUTICALS LTD、 AURO PEPTIDES LTD、 USV PRIVATE LTD、 SUN PHARMACEUTICAL INDUSTRIES LTD、 CIPLA LTD、 DR REDDYS LABORATORIES LTD、 MYLAN LABORATORIES LTD、 BIOPHORE INDIA PHARMACEUTICALS PVT LTD、 MSN LIFE SCIENCES PRIVATE LTD、 TEVA PHARMACEUTICAL INDUSTRIES LTD、 AMBIOPHARM INC、 BCN PEPTIDES SA、 BACHEM AG、 JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD、 CHENGDU SHENGNUO BIOPHARM CO LTDなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。 本調査資料では、製品タイプ、用途、主要メーカー、主要地域、国別の医薬品用酢酸イカチバント市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。 【市場細分化】 本調査では医薬品用酢酸イカチバント市場をセグメンテーションし、種類別 (純度≧99%、純度<99%)、用途別 (注射剤、その他)、および地域別 (アジア太平洋、南北アメリカ、欧州、および中東・アフリカ) の市場規模を予測しています。 ・種類別区分：純度≧99%、純度<99% ・用途別区分：注射剤、その他 ・地域別区分 南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル） アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア） 欧州（ドイツ、フランス、イギリス、イタリア、ロシア） 中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国） 【本レポートで扱う主な質問】 ・世界の医薬品用酢酸イカチバント市場の10年間の市場状況・展望は？ ・世界および地域別に見た医薬品用酢酸イカチバント市場成長の要因は何か？ ・医薬品用酢酸イカチバントの市場機会はエンドマーケットの規模によってどのように変化するのか？ ・医薬品用酢酸イカチバントのタイプ別、用途別の内訳は？ ・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？ ********* 目次 ********* レポートの範囲 ・市場の紹介 ・分析対象期間 ・調査の目的 ・調査手法 ・調査プロセスおよびデータソース ・経済指標 ・通貨 エグゼクティブサマリー ・世界市場の概要：医薬品用酢酸イカチバントの年間販売量2018-2029、地域別現状・将来分析 ・医薬品用酢酸イカチバントの種類別セグメント：純度≧99%、純度<99% ・医薬品用酢酸イカチバントの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格 ・医薬品用酢酸イカチバントの用途別セグメント：注射剤、その他 ・医薬品用酢酸イカチバントの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格 企業別世界の医薬品用酢酸イカチバント市場 ・企業別のグローバル医薬品用酢酸イカチバント市場データ：2018-2023年の年間販売量、市場シェア ・企業別の医薬品用酢酸イカチバントの年間売上：2018-2023年の売上、市場シェア ・企業別の医薬品用酢酸イカチバント販売価格 ・主要企業の医薬品用酢酸イカチバント生産地域、販売地域、製品タイプ ・市場集中度分析 ・新製品および潜在的な参加者 ・合併と買収、拡大 医薬品用酢酸イカチバントの地域別レビュー ・地域別の医薬品用酢酸イカチバント市場規模2018-2023：年間販売量、売上 ・主要国別の医薬品用酢酸イカチバント市場規模2018-2023：年間販売量、売上 ・南北アメリカの医薬品用酢酸イカチバント販売の成長 ・アジア太平洋の医薬品用酢酸イカチバント販売の成長 ・欧州の医薬品用酢酸イカチバント販売の成長 ・中東・アフリカの医薬品用酢酸イカチバント販売の成長 南北アメリカ市場 ・南北アメリカの国別の医薬品用酢酸イカチバント販売量、売上（2018-2023） ・南北アメリカの医薬品用酢酸イカチバントの種類別販売量 ・南北アメリカの医薬品用酢酸イカチバントの用途別販売量 ・アメリカ市場 ・カナダ市場 ・メキシコ市場 ・ブラジル市場 アジア太平洋市場 ・アジア太平洋の国別の医薬品用酢酸イカチバント販売量、売上（2018-2023） ・アジア太平洋の医薬品用酢酸イカチバントの種類別販売量 ・アジア太平洋の医薬品用酢酸イカチバントの用途別販売量 ・中国市場 ・日本市場 ・韓国市場 ・東南アジア市場 ・インド市場 ・オーストラリア市場 ・台湾市場 欧州市場 ・欧州の国別の医薬品用酢酸イカチバント販売量、売上（2018-2023） ・欧州の医薬品用酢酸イカチバントの種類別販売量 ・欧州の医薬品用酢酸イカチバントの用途別販売量 ・ドイツ市場 ・フランス市場 ・イギリス市場 ・イタリア市場 ・ロシア市場 中東・アフリカ市場 ・中東・アフリカの国別の医薬品用酢酸イカチバント販売量、売上（2018-2023） ・中東・アフリカの医薬品用酢酸イカチバントの種類別販売量 ・中東・アフリカの医薬品用酢酸イカチバントの用途別販売量 ・エジプト市場 ・南アフリカ市場 ・イスラエル市場 ・トルコ市場 ・GCC諸国市場 市場の成長要因、課題、動向 ・市場の成長要因および成長機会分析 ・市場の課題およびリスク ・市場動向 製造コスト構造分析 ・原材料とサプライヤー ・医薬品用酢酸イカチバントの製造コスト構造分析 ・医薬品用酢酸イカチバントの製造プロセス分析 ・医薬品用酢酸イカチバントの産業チェーン構造 マーケティング、販売業者および顧客 ・販売チャンネル：直接販売チャンネル、間接販売チャンネル ・医薬品用酢酸イカチバントの主要なグローバル販売業者 ・医薬品用酢酸イカチバントの主要なグローバル顧客 地域別の医薬品用酢酸イカチバント市場予測レビュー ・地域別の医薬品用酢酸イカチバント市場規模予測（2024-2029） ・南北アメリカの国別予測 ・アジア太平洋の国別予測 ・欧州の国別予測 ・医薬品用酢酸イカチバントの種類別市場規模予測 ・医薬品用酢酸イカチバントの用途別市場規模予測 主要企業分析 ALEMBIC PHARMACEUTICALS LTD、 AURO PEPTIDES LTD、 USV PRIVATE LTD、 SUN PHARMACEUTICAL INDUSTRIES LTD、 CIPLA LTD、 DR REDDYS LABORATORIES LTD、 MYLAN LABORATORIES LTD、 BIOPHORE INDIA PHARMACEUTICALS PVT LTD、 MSN LIFE SCIENCES PRIVATE LTD、 TEVA PHARMACEUTICAL INDUSTRIES LTD、 AMBIOPHARM INC、 BCN PEPTIDES SA、 BACHEM AG、 JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD、 CHENGDU SHENGNUO BIOPHARM CO LTD ・企業情報 ・医薬品用酢酸イカチバント製品 ・医薬品用酢酸イカチバント販売量、売上、価格、粗利益（2018-2023） ・主要ビジネス概要 ・最新動向 調査結果および結論 |
The global Pharmaceutical Grade Icatibant Acetate market size is projected to grow from US$ 426.5 million in 2022 to US$ 629 million in 2029; it is expected to grow at a CAGR of 5.7% from 2023 to 2029.
United States market for Pharmaceutical Grade Icatibant Acetate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pharmaceutical Grade Icatibant Acetate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pharmaceutical Grade Icatibant Acetate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pharmaceutical Grade Icatibant Acetate players cover ALEMBIC PHARMACEUTICALS LTD, AURO PEPTIDES LTD, USV PRIVATE LTD, SUN PHARMACEUTICAL INDUSTRIES LTD, CIPLA LTD, DR REDDYS LABORATORIES LTD, MYLAN LABORATORIES LTD, BIOPHORE INDIA PHARMACEUTICALS PVT LTD and MSN LIFE SCIENCES PRIVATE LTD, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Pharmaceutical Grade Icatibant Acetate Industry Forecast” looks at past sales and reviews total world Pharmaceutical Grade Icatibant Acetate sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Grade Icatibant Acetate sales for 2023 through 2029. With Pharmaceutical Grade Icatibant Acetate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Grade Icatibant Acetate industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Grade Icatibant Acetate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Grade Icatibant Acetate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Grade Icatibant Acetate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Grade Icatibant Acetate and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Grade Icatibant Acetate.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Grade Icatibant Acetate market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Purity≥99%
Purity<99%
Segmentation by application
Injection
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
ALEMBIC PHARMACEUTICALS LTD
AURO PEPTIDES LTD
USV PRIVATE LTD
SUN PHARMACEUTICAL INDUSTRIES LTD
CIPLA LTD
DR REDDYS LABORATORIES LTD
MYLAN LABORATORIES LTD
BIOPHORE INDIA PHARMACEUTICALS PVT LTD
MSN LIFE SCIENCES PRIVATE LTD
TEVA PHARMACEUTICAL INDUSTRIES LTD
AMBIOPHARM INC
BCN PEPTIDES SA
BACHEM AG
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD
CHENGDU SHENGNUO BIOPHARM CO LTD
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pharmaceutical Grade Icatibant Acetate market?
What factors are driving Pharmaceutical Grade Icatibant Acetate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceutical Grade Icatibant Acetate market opportunities vary by end market size?
How does Pharmaceutical Grade Icatibant Acetate break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Grade Icatibant Acetate Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pharmaceutical Grade Icatibant Acetate by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pharmaceutical Grade Icatibant Acetate by Country/Region, 2018, 2022 & 2029
2.2 Pharmaceutical Grade Icatibant Acetate Segment by Type
2.2.1 Purity≥99%
2.2.2 Purity<99%
2.3 Pharmaceutical Grade Icatibant Acetate Sales by Type
2.3.1 Global Pharmaceutical Grade Icatibant Acetate Sales Market Share by Type (2018-2023)
2.3.2 Global Pharmaceutical Grade Icatibant Acetate Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pharmaceutical Grade Icatibant Acetate Sale Price by Type (2018-2023)
2.4 Pharmaceutical Grade Icatibant Acetate Segment by Application
2.4.1 Injection
2.4.2 Others
2.5 Pharmaceutical Grade Icatibant Acetate Sales by Application
2.5.1 Global Pharmaceutical Grade Icatibant Acetate Sale Market Share by Application (2018-2023)
2.5.2 Global Pharmaceutical Grade Icatibant Acetate Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pharmaceutical Grade Icatibant Acetate Sale Price by Application (2018-2023)
3 Global Pharmaceutical Grade Icatibant Acetate by Company
3.1 Global Pharmaceutical Grade Icatibant Acetate Breakdown Data by Company
3.1.1 Global Pharmaceutical Grade Icatibant Acetate Annual Sales by Company (2018-2023)
3.1.2 Global Pharmaceutical Grade Icatibant Acetate Sales Market Share by Company (2018-2023)
3.2 Global Pharmaceutical Grade Icatibant Acetate Annual Revenue by Company (2018-2023)
3.2.1 Global Pharmaceutical Grade Icatibant Acetate Revenue by Company (2018-2023)
3.2.2 Global Pharmaceutical Grade Icatibant Acetate Revenue Market Share by Company (2018-2023)
3.3 Global Pharmaceutical Grade Icatibant Acetate Sale Price by Company
3.4 Key Manufacturers Pharmaceutical Grade Icatibant Acetate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceutical Grade Icatibant Acetate Product Location Distribution
3.4.2 Players Pharmaceutical Grade Icatibant Acetate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pharmaceutical Grade Icatibant Acetate by Geographic Region
4.1 World Historic Pharmaceutical Grade Icatibant Acetate Market Size by Geographic Region (2018-2023)
4.1.1 Global Pharmaceutical Grade Icatibant Acetate Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pharmaceutical Grade Icatibant Acetate Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pharmaceutical Grade Icatibant Acetate Market Size by Country/Region (2018-2023)
4.2.1 Global Pharmaceutical Grade Icatibant Acetate Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pharmaceutical Grade Icatibant Acetate Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pharmaceutical Grade Icatibant Acetate Sales Growth
4.4 APAC Pharmaceutical Grade Icatibant Acetate Sales Growth
4.5 Europe Pharmaceutical Grade Icatibant Acetate Sales Growth
4.6 Middle East & Africa Pharmaceutical Grade Icatibant Acetate Sales Growth
5 Americas
5.1 Americas Pharmaceutical Grade Icatibant Acetate Sales by Country
5.1.1 Americas Pharmaceutical Grade Icatibant Acetate Sales by Country (2018-2023)
5.1.2 Americas Pharmaceutical Grade Icatibant Acetate Revenue by Country (2018-2023)
5.2 Americas Pharmaceutical Grade Icatibant Acetate Sales by Type
5.3 Americas Pharmaceutical Grade Icatibant Acetate Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Grade Icatibant Acetate Sales by Region
6.1.1 APAC Pharmaceutical Grade Icatibant Acetate Sales by Region (2018-2023)
6.1.2 APAC Pharmaceutical Grade Icatibant Acetate Revenue by Region (2018-2023)
6.2 APAC Pharmaceutical Grade Icatibant Acetate Sales by Type
6.3 APAC Pharmaceutical Grade Icatibant Acetate Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pharmaceutical Grade Icatibant Acetate by Country
7.1.1 Europe Pharmaceutical Grade Icatibant Acetate Sales by Country (2018-2023)
7.1.2 Europe Pharmaceutical Grade Icatibant Acetate Revenue by Country (2018-2023)
7.2 Europe Pharmaceutical Grade Icatibant Acetate Sales by Type
7.3 Europe Pharmaceutical Grade Icatibant Acetate Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Grade Icatibant Acetate by Country
8.1.1 Middle East & Africa Pharmaceutical Grade Icatibant Acetate Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pharmaceutical Grade Icatibant Acetate Revenue by Country (2018-2023)
8.2 Middle East & Africa Pharmaceutical Grade Icatibant Acetate Sales by Type
8.3 Middle East & Africa Pharmaceutical Grade Icatibant Acetate Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Grade Icatibant Acetate
10.3 Manufacturing Process Analysis of Pharmaceutical Grade Icatibant Acetate
10.4 Industry Chain Structure of Pharmaceutical Grade Icatibant Acetate
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharmaceutical Grade Icatibant Acetate Distributors
11.3 Pharmaceutical Grade Icatibant Acetate Customer
12 World Forecast Review for Pharmaceutical Grade Icatibant Acetate by Geographic Region
12.1 Global Pharmaceutical Grade Icatibant Acetate Market Size Forecast by Region
12.1.1 Global Pharmaceutical Grade Icatibant Acetate Forecast by Region (2024-2029)
12.1.2 Global Pharmaceutical Grade Icatibant Acetate Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pharmaceutical Grade Icatibant Acetate Forecast by Type
12.7 Global Pharmaceutical Grade Icatibant Acetate Forecast by Application
13 Key Players Analysis
13.1 ALEMBIC PHARMACEUTICALS LTD
13.1.1 ALEMBIC PHARMACEUTICALS LTD Company Information
13.1.2 ALEMBIC PHARMACEUTICALS LTD Pharmaceutical Grade Icatibant Acetate Product Portfolios and Specifications
13.1.3 ALEMBIC PHARMACEUTICALS LTD Pharmaceutical Grade Icatibant Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 ALEMBIC PHARMACEUTICALS LTD Main Business Overview
13.1.5 ALEMBIC PHARMACEUTICALS LTD Latest Developments
13.2 AURO PEPTIDES LTD
13.2.1 AURO PEPTIDES LTD Company Information
13.2.2 AURO PEPTIDES LTD Pharmaceutical Grade Icatibant Acetate Product Portfolios and Specifications
13.2.3 AURO PEPTIDES LTD Pharmaceutical Grade Icatibant Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AURO PEPTIDES LTD Main Business Overview
13.2.5 AURO PEPTIDES LTD Latest Developments
13.3 USV PRIVATE LTD
13.3.1 USV PRIVATE LTD Company Information
13.3.2 USV PRIVATE LTD Pharmaceutical Grade Icatibant Acetate Product Portfolios and Specifications
13.3.3 USV PRIVATE LTD Pharmaceutical Grade Icatibant Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 USV PRIVATE LTD Main Business Overview
13.3.5 USV PRIVATE LTD Latest Developments
13.4 SUN PHARMACEUTICAL INDUSTRIES LTD
13.4.1 SUN PHARMACEUTICAL INDUSTRIES LTD Company Information
13.4.2 SUN PHARMACEUTICAL INDUSTRIES LTD Pharmaceutical Grade Icatibant Acetate Product Portfolios and Specifications
13.4.3 SUN PHARMACEUTICAL INDUSTRIES LTD Pharmaceutical Grade Icatibant Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 SUN PHARMACEUTICAL INDUSTRIES LTD Main Business Overview
13.4.5 SUN PHARMACEUTICAL INDUSTRIES LTD Latest Developments
13.5 CIPLA LTD
13.5.1 CIPLA LTD Company Information
13.5.2 CIPLA LTD Pharmaceutical Grade Icatibant Acetate Product Portfolios and Specifications
13.5.3 CIPLA LTD Pharmaceutical Grade Icatibant Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 CIPLA LTD Main Business Overview
13.5.5 CIPLA LTD Latest Developments
13.6 DR REDDYS LABORATORIES LTD
13.6.1 DR REDDYS LABORATORIES LTD Company Information
13.6.2 DR REDDYS LABORATORIES LTD Pharmaceutical Grade Icatibant Acetate Product Portfolios and Specifications
13.6.3 DR REDDYS LABORATORIES LTD Pharmaceutical Grade Icatibant Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 DR REDDYS LABORATORIES LTD Main Business Overview
13.6.5 DR REDDYS LABORATORIES LTD Latest Developments
13.7 MYLAN LABORATORIES LTD
13.7.1 MYLAN LABORATORIES LTD Company Information
13.7.2 MYLAN LABORATORIES LTD Pharmaceutical Grade Icatibant Acetate Product Portfolios and Specifications
13.7.3 MYLAN LABORATORIES LTD Pharmaceutical Grade Icatibant Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 MYLAN LABORATORIES LTD Main Business Overview
13.7.5 MYLAN LABORATORIES LTD Latest Developments
13.8 BIOPHORE INDIA PHARMACEUTICALS PVT LTD
13.8.1 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Company Information
13.8.2 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Pharmaceutical Grade Icatibant Acetate Product Portfolios and Specifications
13.8.3 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Pharmaceutical Grade Icatibant Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Main Business Overview
13.8.5 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Latest Developments
13.9 MSN LIFE SCIENCES PRIVATE LTD
13.9.1 MSN LIFE SCIENCES PRIVATE LTD Company Information
13.9.2 MSN LIFE SCIENCES PRIVATE LTD Pharmaceutical Grade Icatibant Acetate Product Portfolios and Specifications
13.9.3 MSN LIFE SCIENCES PRIVATE LTD Pharmaceutical Grade Icatibant Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 MSN LIFE SCIENCES PRIVATE LTD Main Business Overview
13.9.5 MSN LIFE SCIENCES PRIVATE LTD Latest Developments
13.10 TEVA PHARMACEUTICAL INDUSTRIES LTD
13.10.1 TEVA PHARMACEUTICAL INDUSTRIES LTD Company Information
13.10.2 TEVA PHARMACEUTICAL INDUSTRIES LTD Pharmaceutical Grade Icatibant Acetate Product Portfolios and Specifications
13.10.3 TEVA PHARMACEUTICAL INDUSTRIES LTD Pharmaceutical Grade Icatibant Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 TEVA PHARMACEUTICAL INDUSTRIES LTD Main Business Overview
13.10.5 TEVA PHARMACEUTICAL INDUSTRIES LTD Latest Developments
13.11 AMBIOPHARM INC
13.11.1 AMBIOPHARM INC Company Information
13.11.2 AMBIOPHARM INC Pharmaceutical Grade Icatibant Acetate Product Portfolios and Specifications
13.11.3 AMBIOPHARM INC Pharmaceutical Grade Icatibant Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 AMBIOPHARM INC Main Business Overview
13.11.5 AMBIOPHARM INC Latest Developments
13.12 BCN PEPTIDES SA
13.12.1 BCN PEPTIDES SA Company Information
13.12.2 BCN PEPTIDES SA Pharmaceutical Grade Icatibant Acetate Product Portfolios and Specifications
13.12.3 BCN PEPTIDES SA Pharmaceutical Grade Icatibant Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 BCN PEPTIDES SA Main Business Overview
13.12.5 BCN PEPTIDES SA Latest Developments
13.13 BACHEM AG
13.13.1 BACHEM AG Company Information
13.13.2 BACHEM AG Pharmaceutical Grade Icatibant Acetate Product Portfolios and Specifications
13.13.3 BACHEM AG Pharmaceutical Grade Icatibant Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 BACHEM AG Main Business Overview
13.13.5 BACHEM AG Latest Developments
13.14 JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD
13.14.1 JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD Company Information
13.14.2 JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD Pharmaceutical Grade Icatibant Acetate Product Portfolios and Specifications
13.14.3 JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD Pharmaceutical Grade Icatibant Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD Main Business Overview
13.14.5 JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD Latest Developments
13.15 CHENGDU SHENGNUO BIOPHARM CO LTD
13.15.1 CHENGDU SHENGNUO BIOPHARM CO LTD Company Information
13.15.2 CHENGDU SHENGNUO BIOPHARM CO LTD Pharmaceutical Grade Icatibant Acetate Product Portfolios and Specifications
13.15.3 CHENGDU SHENGNUO BIOPHARM CO LTD Pharmaceutical Grade Icatibant Acetate Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 CHENGDU SHENGNUO BIOPHARM CO LTD Main Business Overview
13.15.5 CHENGDU SHENGNUO BIOPHARM CO LTD Latest Developments
14 Research Findings and Conclusion